Volume 8 | Issue - 10
Volume 8 | Issue - 10
Volume 8 | Issue - 10
Volume 8 | Issue - 10
Volume 8 | Issue - 9
Background and Objective: Reduced plasma levels of antithrombin III have been observed in pregnant mothers with preeclampsia. However, there is very limited information about the relationship between antithrombin, preeclampsia, and chronic hypertension during pregnancy. Methods: This case-control study included 120 pregnant mothers who were divided into three groups including preeclampsia, chronic hypertension, and control (40 in each group). Women with twin or multiple pregnancies or fetuses with hydatidiform mole and hydrops fetalis were excluded from the study. All people with diabetes, liver disease, kidney disease, etc., and infectious diseases were excluded from the study. Testing and sampling were simultaneous with the termination of pregnancy in three groups. One cc was sampled from the subjects. After completion, the data were entered into SPSS 17 software and analyzed using an independent t-test and chi-square test with a significance level of less than 0.05. Results: The mean and standard deviation of serum antithrombin III levels were 18.80 ± 5.30 mg/dL in women of the chronic hypertension group, 20.11 ± 7.52 mg/dL in women of the preeclampsia group, and 19.44 ± 6.07 mg/dL in women of the control group (P>0.05). A pairwise comparison of the mean serum antithrombin III levels of patients using the Tukey HSD post hoc test revealed that this difference was not statistically significant between any of the two study groups (P>0.05). In the chronic hypertension group, 22 cases (55%) had abnormal antithrombin III levels, in the preeclampsia group, 21 cases (52.5%) had abnormal antithrombin III levels, and 19 cases in the control women (47.5%) had abnormal antithrombin III levels (less than 20 mg/dL) (P>0.05). Conclusion: The results revealed that despite the differences in the etiologies of preeclampsia and chronic hypertension and the known role of antithrombin III in these diseases and pregnancy, there was no statistically significant difference between the plasma levels of antithrombin III in the three study groups including pregnant women with preeclampsia, pregnant women with chronic hypertension, and healthy pregnant mothers.